Life insurers have taken a fresh look at their established traditional underwriting practices as they consider and implement streamlined accelerated underwriting (AU) options, removing the need for paramedical exams and/or fluid collection for qualified applicants.
When you have deployed an underwriting engine, that is not the end of the journey. Quite the opposite: it is just the beginning.
Dr. Achim Regenauer shares an overview of this important study’s findings and his perspective on the impact on cancer detection and Life & Health insurance.
A Pivotal Role in an Era of Acceleration and Change: How Actuaries and Underwriters Can Partner to Facilitate Innovation
As part of an ongoing series in On the Risk, RGA's Taylor Pickett, an actuary, and Catie Muccigrosso, an underwriter, examine the relationship between their professions and underscore the crucial role underwriters play in the development and implementation of predictive tools and accurate pricing.
Many applications have APS trails that read like a suspense novel. There is a medical condition, oftentimes a serious one, that has an intervention, and the trail ends. Perhaps it is a chronic condition, with unknown degree of control or stability that leaves no clue as to the present status.
Hypertension, or high blood pressure, is a common medical problem. It can be caused by a number of other medical conditions such as chronic kidney disease, thyroid disorders and other hormonal upsets, and a rare adrenal gland tumor called pheochromocytoma.
Post-traumatic stress disorder (PTSD) was first introduced into the Diagnostic and Statistical Manual (DSM) of the American Psychological Association in 1980. Since then, the diagnostic guidelines have been reviewed multiple times, and the understanding of risk factors, neurobiological consequences and psychological symptoms has improved dramatically.
RGA’s consultant oncologist, Dr. Radi Counsell, discusses the ways liquid biopsies will change the face of cancer care, from screening and diagnosis to treatment monitoring and surveillance of survivors. Dr. Counsell also examines underwriting and claims adjudication implications of this emerging technology.
One of the most difficult calls facing an underwriter is the discussion with a producer who insists that his client has been unfairly rated due to an improper fasting time prior to blood drawing
During the pandemic, we’ve had fewer in‑person interactions and done more things remotely. A positive is that we are becoming better at using technologies that fit this new normal. The question is whether or not technology can be adapted to allow for socially distanced, fast and effective medical risk assessment and if successful, can it help invigorate underwriting?